Tao Zhu

CanSino Biologics Inc.

Tianjin

China

SCHOLARLY PAPERS

6

DOWNLOADS

939

SSRN CITATIONS

1

CROSSREF CITATIONS

0

Scholarly Papers (6)

1.

Safety and Immunogenicity of Heterologous Boost Immunisation With an Aerosolized Ad5-nCoV After Two-Dose Priming With an Inactivated SARS-CoV-2 Vaccine CoronaVac in Adults: A Randomised, Open-Label, Parallel-Control Trial

Number of pages: 26 Posted: 04 Jan 2022
Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Academy of Military Medical Sciences - Institute of Biotechnology, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Collaborative Innovation Center for Diagnosis Treatment of Infectious Diseases - NHC Key Laboratory of Biosafety, Donghai County Center for Disease Control and Prevention, CanSino Biologics Inc., Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Academy of Military Medical Sciences - Institute of Biotechnology, CanSino Biologics Inc., Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, CanSino Biologics Inc., Donghai County Center for Disease Control and Prevention, CanSino Biologics Inc., Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, CanSino Biologics Inc., Nanjing Vazyme Biotech Co., Ltd., Nanjing Medical University - School of Public Health, Southeast University - School of Public Health, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, CanSino Biologics Inc., Collaborative Innovation Center for Diagnosis Treatment of Infectious Diseases - NHC Key Laboratory of Biosafety, Academy of Military Medical Sciences - Institute of Biotechnology and Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology
Downloads 452 (120,071)
Citation 1

Abstract:

Loading...

Heterologous boost, aerosolized adenovirus type-5 vector-based COVID-19 vaccine, safety, immunogenicity, inactivated COVID-19 vaccine, clinical trial

2.

Safety, Immunogenicity and Efficacy of the mRNA Vaccine CS-2034 as a Heterologous Booster Versus Homologous Booster with BBIBP-CorV in Adults Aged ≥18 Years: A Randomized, Partial-Blind, Phase 2b Trial

Number of pages: 25 Posted: 15 Feb 2023
Yixing People's Hospital, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, CanSino Biologics Inc., CanSino Biologics Inc., Yixing People's Hospital, CanSino Biologics Inc., CanSino Biologics Inc., Yixing People's Hospital, Yixing People's Hospital, CanSino Biologics Inc., Yixing People's Hospital, CanSino Biologics Inc., CanSino Biologics Inc., CanSino Biologics Inc., CanSino Biologics Inc., Guangzhou Laboratory, CanSino Biologics Inc., CanSino Biologics Inc., CanSino Biologics Inc., Guangzhou Medical University - State Key Laboratory of Respiratory Disease and Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology
Downloads 192 (291,509)

Abstract:

Loading...

SARS-CoV-2, Omicron, heterologous booster, homologous booster, mRNA vaccine CS-2034, safety, immunogenicity

3.

Safety and Immunogenicity of Aerosolised Ad5-nCoV or Intramuscular Ad5-nCoV or Inactivated COVID-19 Vaccine Coronavac Given as the Second Booster Following Three Doses of CoronaVac: A Multicentre, Open-Label, Phase 4, Randomized Trial

Number of pages: 24 Posted: 30 Dec 2022
Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Southeast University - School of Public Health, Academy of Military Medical Sciences - Institute of Biotechnology, CanSino Biologics Inc., Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Donghai County Center for Disease Control and Prevention, CanSino Biologics Inc., Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Academy of Military Medical Sciences - Institute of Biotechnology, CanSino Biologics Inc., Donghai County Center for Disease Control and Prevention, CanSino Biologics Inc., Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Lianshui Center for Disease Control and Prevention, CanSino Biologics Inc., Nanjing Vazyme Biotech Co., Ltd., Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Nanjing Medical University - School of Public Health, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Southeast University - School of Public Health, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Lianshui Center for Disease Control and Prevention, CanSino Biologics Inc., Academy of Military Medical Sciences - Institute of Biotechnology, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology and Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology
Downloads 118 (434,362)

Abstract:

Loading...

4.

Safety, Immunogenicity and Efficacy of Heterologous Boost with an Aerosolized Ad5-nCoV after Two-Dose Priming with Inactivated COVID-19 Vaccines in Adults: A Multicenter, Open-Label Trial

Number of pages: 25 Posted: 07 Apr 2023
Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Academy of Military Medical Sciences - Institute of Biotechnology, CanSino Biologics Inc., Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Collaborative Innovation Center for Diagnosis Treatment of Infectious Diseases - National Immunization Program, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Academy of Military Medical Sciences - Institute of Biotechnology, Harbin Medical University - Chinese Center for Disease Control and Prevention, Academy of Military Medical Sciences - Institute of Biotechnology, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Government of the People's Republic of China - Center of Disease Control and Prevention, Chongqing Center for Disease Control and Prevention, Nanjing Medical University - School of Public Health, Anhui Provincial Center for Disease Control and Prevention, Chongqing Center for Disease Control and Prevention, Anhui Provincial Center for Disease Control and Prevention, Yunan Provincial Center for Disease Control and Prevention, Hunan Provincial Center for Disease Control and Prevention, Anhui Provincial Center for Disease Control and Prevention, Hunan Provincial Center for Disease Control and Prevention, Yunan Provincial Center for Disease Control and Prevention, CanSino Biologics Inc., Nanjing Medical University - Department of Epidemiology and Biostatistics, Academy of Military Medical Sciences - Institute of Biotechnology and Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology
Downloads 111 (454,685)

Abstract:

Loading...

Safety, Immunogenicity, Long-term efficacy, Aerosolized Ad5-nCoV, Booster

5.

Safety, Immunogenicity, and Efficacy of Recombinant COVID-19 Inhalation Vaccine (Adenovirus Type 5 Vector) as Second Booster Dose Against Emerging Variants of Concern (VOC) of SARS-CoV-2 to Prevent Breakthrough Infections: An Observer-Blinded, Randomised, Phase 3, Non-Inferiority Trial

Number of pages: 31 Posted: 18 Mar 2024
Institute for Clinical Research, CanSino Biologics Inc., Hospital Kuala Lumpur, Selayang Hospital, CanSino Biologics Inc., CanSino Biologics Inc., Institute for Clinical Research, Academy of Military Medical Sciences - Institute of Biotechnology, Hospital Kuala Lumpur, Selayang Hospital, Institute for Clinical Research, Hospital Kuala Lumpur, CanSino Biologics Inc., University of Malaya (UM), Academy of Military Medical Sciences - Institute of Biotechnology, Academy of Military Medical Sciences - Institute of Biotechnology, CanSino Biologics Inc., CanSino Biologics Inc., Clin Research Private Enterprise, CanSino Biologics Inc., Institute for Clinical Research and Independent
Downloads 52 (701,806)

Abstract:

Loading...

COVID-19 vaccines, inhaled vaccines, immunogenicity, SARS-CoV-2, Ad5-CoV, aerosol inhalation, booster

6.

Self-Enhanced Ptx@Hsa-Ha Loaded Functionalized Injectable Hydrogel for Effective Local Chemo-Photothermal Therapy in Breast Cancer

Number of pages: 51 Posted: 13 Apr 2024
Tianjin University - Tianjin University of Science and Technology, Tianjin University - Tianjin University of Science and Technology, Tianjin University - Tianjin University of Science and Technology, Tianjin University - Tianjin University of Science and Technology, Tianjin University - Tianjin University of Science and Technology, affiliation not provided to SSRN, affiliation not provided to SSRN, CanSino Biologics Inc., affiliation not provided to SSRN and Tianjin University - Tianjin University of Science and Technology
Downloads 14 (1,016,184)

Abstract:

Loading...

Injectable hydrogel, Hyaluronic acid, Nanoparticles, Chemo-photothermal therapy, Breast cancer